Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Patent
1991-06-19
1995-03-21
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
424 43, 424450, 424 851, 424 852, A61K 912
Patent
active
053993411
ABSTRACT:
The invention provides a method of treating tumors by the use of cytokin-containing aerosols for inhalative application and immuno-activation or continuous-immuno regulation in tumor diseases. The invention further proposes the use of cytokin-containing substances for producing an aerosol medicinal preparation for inhalative application and immuno-activation or continuous immuno-regulation in tumor diseases.
REFERENCES:
patent: 5011678 (1991-04-01), Wang et al.
patent: 5037644 (1991-08-01), Shaked et al.
patent: 5049389 (1991-09-01), Ladhakrishnan
patent: 5162507 (1992-11-01), Wolfe et al.
Cancer, vol. 58, pp. 2764-2772 (1986).
Lotze, M. T., et al, "Clinical Effects and Toxicity of Interleukin-2 in Patients With Cancer" Cancer 58: 2764, 1986.
Thompson, J. A., et al, "Recombinant Interleukin-2 Toxicity, Pharmacokinetics, and Immunomodulatory Effects in a Phase 1 Trial" Cancer Res. 47:4202, 1987.
West, W. H., et al, "Constant-Infusion Recombinant-Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer" N. Engl. J. Med.: 898, 1987.
Lotze, M. T., et al, "High-Dose Recombinant Interleukin-2 in The Treatment of Patients with Disseminated Cancer" J.A.M.A. 256:3117, 1986.
Rosenberg, S. A., et al, "A Progress Report on the Treatment of 157 Patients with Advanced Cancer using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone" New Engl. J. Med. 316: 898, 1987.
Kucharz, E. J., et al. "Serum Inhibitors of Interleukin-2" Life Sci. 42: 1485, 1988.
Forni G., et al. "Tumor Immunotherapy by Local Injection of Interleukin-2 and Non-Reactive Lymphocytes", Prog. Exp. Tumor Res. 32: 187, 1988.
Gramatzki, M. et al, "Intralymphatic Interleukin-2 Treatment in Patients with Acquired Immunodeficiency Syndrome: Preliminary Experience in Three Case" Immunobiol. 172:438, 1986.
Bubenik, J. "Local immunotherapy of cancer with interleukin-2", Immunol. Let. 21: 267, 1989.
Lotze, M. T., et al. "Intraperitoneal Administration of Interleukin-2 in Patients with Cancer" Arch. Surg. 121: 1373, 1986.
Yasumoto, K., et al. "Induction of Lymphokine-activated Killer Cells by Intrapleural Instillations of Recombinant Interleukin-2 in Patients with Malignant Pleurisy Due to Lung Cancer" Cancer Res. 47: 2184, 1987.
Rosenberg, S. A. "Immunotherapy of Cancer by Systemic Admin. of Lymphoid Cells Plus Interleukin-2", J. Biol. Resp Mod 3: 501, 1984.
Mittelman, A., et al, "Treatment of Patients with Advanced Cancer Using Multiple Long-Term Cultured Lymphokine-Activated Killer (LAK) Cell Infusions and Recombinant Human Interleukin-2", J. Biol. Resp. Mod. 8: 468, 1989.
Rosenberg, S. A. "Lymphokine-Activated Killer Cells: A New Approach to Immunotherapy of Cancer", J.N.C.I. 75: 595, 1985.
Paciucci, P. A., et al, "Recombinant Interleukin-2 by Continuous Infusion and Adoptive Transfer of Recombinant Interleukin-2-Activated Cells in Patients with Advanced Cancer", J. Clin. Oncol. 7: 869, 1989.
Grimm, E. A., et al, "Lymphokine-Activated Killer Cell Phenomenon", J. Exp. Med. 155: 1823, 1982.
Rosenberg, S. A. "Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 To Patients with Metastatic Cancer", N. Engl. J. Med. 313: 1485, 1985.
Belldegrun, A., "Lymphokines and activated cells in experimental and clinical immunotherapy" In: Immunotherapy of Urological Tumors (ed. deKernion JB), Churchill Livingston 1990.
Huland Edith
Huland Hartwig
Bawa Raj
Page Thurman K.
Roberts Richard S.
LandOfFree
Use of cytokin-containing aerosols and the cytokin-containing ae does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cytokin-containing aerosols and the cytokin-containing ae, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cytokin-containing aerosols and the cytokin-containing ae will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1147359